Riskpilot← Back to searchSign inGet full accessWerlabs AB
ABActiveOrg 5568608649Hälsingegatan 40 6 TrGeneral medical practice activities · NACE 8621Est. 201120-49 employees
Revenue 2024
SEK 104M
+14% vs 2023
EBITDA margin
-8.1%
+68% vs 2023
Equity ratio
57.0%
Financial strength
Net profit 2024
SEK -7,7M
+70% vs 2023
| Revenue | SEK 104M | +14% |
| EBITDA | SEK -8,4M | +68% |
| Net profit | SEK -7,7M | +70% |
| Total assets | SEK 34,2M | -11% |
| Equity | SEK 19,5M | -23% |
| Employees | — | — |
Legal name
Werlabs AB
Org number
5568608649
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
10 augusti 2011
Share capital
SEK 157 000
Employees
20-49
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Aktiebolaget ska vara verksamt inom tester och analyser av blod. Vidare ska aktiebolaget vara verksamt inom andra hälsotester och hälsoanalyser.
Address
Hälsingegatan 40 6 Tr
Phone
+468207050
Email
finance@werlabs.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 43 955 | 54 644 | 190 458 | 239 188 | 112 548 | 91 099 | 103 990 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −2 615 | −15 809 | −43 288 | −42 222 | −13 905 | 14 183 | 19 628 | −23 930 | −26 583 | −8 394 |
| Depreciation & amort. | −60 | −255 | −284 | −295 | −249 | −249 | −109 | −146 | −101 | −64 |
| EBIT | −2 675 | −16 064 | −43 572 | −42 517 | −14 154 | 13 934 | 19 519 | −24 076 | −26 684 | −8 458 |
| Net financials | — | −1 | −46 | −3 | 2 | 8 | 1 | 15 | 815 | 790 |
| Profit before tax | −2 676 | −16 064 | −43 618 | −42 521 | −14 152 | 13 942 | 19 519 | −24 061 | −25 868 | −7 668 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −2 676 | −16 064 | −43 618 | −42 521 | −14 152 | 13 942 | 19 519 | −24 061 | −25 868 | −7 668 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2 826 | 25 603 | 47 110 | 46 582 | 27 785 | 63 600 | 72 399 | 44 142 | 38 581 | 34 212 |
| Equity | 1 618 | 18 990 | 35 312 | 31 149 | 17 959 | 31 746 | 51 349 | 28 065 | 25 453 | 19 505 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 208 | 6 613 | 11 799 | 15 433 | 9 826 | 31 853 | 21 050 | 16 077 | 13 129 | 14 707 |
| Total debt | 1 208 | 6 613 | 11 799 | 15 433 | 9 826 | 31 853 | 21 050 | 16 077 | 13 129 | 14 707 |
EBITDA margin
-8.1%
This company
15.8%
Market median
-151% vs market
20152024
Equity ratio
57.0%
This company
38.2%
Market median
+49% vs market
20152024
Return on equity
-39.3%
This company
18.4%
Market median
-314% vs market
20152024
Net profit margin
-7.4%
This company
8.1%
Market median
-191% vs market
20152024
Asset turnover
3.04×
This company
1.12×
Market median
+171% vs market
20152024
Debt / equity
0.75×
This company
0.62×
Market median
+21% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2014-09-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HJ Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
AM Chief Auditor | Chief Auditor | 2021 | — | — |
CF Chief Auditor | Chief Auditor | 2022 | — | — |
SL Chief Auditor | Chief Auditor | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2024 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Werlabs AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henrik Johan Forsberg | Chief Executive Officer | 0 companies |
| Annie M M Pyk Hammarqvist | Chief Auditor | 0 companies |
| Carl Fredrik Niring | Chief Auditor | 0 companies |
| Sofia Louise Petersson | Chief Auditor | 0 companies |
| Per Henrik Salwén | Board of Directors | 0 companies |
| Jon Erik Ivar Sintorn | Board of Directors | 0 companies |
| Christian L Jepsen | Board of Directors | 0 companies |
| Claes Agne Ekström | Chairman | 0 companies |
| Krim Benaissa Talia | Board of Directors | 0 companies |
| Anna Karolina Levander | Board of Directors | 0 companies |
| Jacob Stedman | Board of Directors | 0 companies |